Press release
Microbiome Therapeutics Market worth $510.87 million by 2030, growing at a CAGR of 21.44% - Exclusive Report by 360iResearch
Microbiome Therapeutics Market | 360iResearch
The Global Microbiome Therapeutics Market to grow from USD 131.09 million in 2023 to USD 510.87 million by 2030, at a CAGR of 21.44%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/microbiome-therapeutics?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Microbiome therapeutics is an emergent area of medicine focused on using microorganisms or their components to prevent, treat, or cure disease. The human microbiome is the collection of trillions of commensal, symbiotic, and pathogenic microorganisms found in and on the human body. Microbiome therapeutics leverage the understanding of this complex ecosystem to develop products that can modify the microbiome in ways that contribute to health and combat disease. The market includes prebiotics, probiotics, postbiotics, and other interventions designed to treat and prevent diseases by influencing the microbiome. An increase in the prevalence of lifestyle-associated diseases, greater understanding of the microbiome in human health and disease, advancements in microbiological research technologies, and a supportive regulatory environment have driven market growth. Despite the potential, the microbiome therapeutics market faces certain challenges, including a lack of standardized regulations, difficulties in proving the efficacy of certain products, and the complexity of the microbiome. Intellectual property issues, high research costs, and reimbursement challenges are additional challenges across the market. Tailoring treatments based on an individual's unique microbiome composition holds promise for therapies' efficacy and success rates. Advances in genomic and metagenomic analytics allow for precision modulation of the microbiome. Moreover, partnerships between pharmaceutical and biotech firms specializing in microbiome research are expanding, potentially leading to new therapeutic discoveries and applications.
In North America, rising chronic disease prevalence and significant health consciousness among consumers have created a robust market for microbiome therapeutics. Advanced research facilities and substantial funding have led to groundbreaking microbial consortia and delivery technology patents. Key investments by major pharma and biotech firms and strategic partnerships propel the market across the region. EU nations collectively represent a vast market for microbiome therapeutics, underpinned by a strong regulatory framework and an emphasis on patient-centric care. Research and development are thriving, supported by European Commission initiatives like Horizon Europe. The European Investment Bank has also actively financed high-potential startups in this sector. Interest in personalized medicine is expanding in the Middle East, albeit with varying degrees across the region. Lifestyle diseases are rising, prompting investments into novel treatments, including microbiome-based therapies. However, the regulatory landscape and market access differ greatly between countries, influencing customer purchasing behavior and market penetration. Africa's market for microbiome therapeutics is nascent but holds potential, primarily due to an increased burden of infectious and lifestyle diseases. The Asia-Pacific (APAC) region presents a rapidly growing market for microbiome therapeutics, fueled by rising healthcare awareness and an increasing prevalence of lifestyle diseases. Countries such as China and Japan are at the forefront, with both nations investing heavily in microbiome research. The APAC market is characterized by many start-ups and local companies venturing into microbiome therapeutics.
Market Segmentation & Coverage:
This research report categorizes the Microbiome Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Type, market is studied across Fecal Microbiota Transplantation, Microbiome Drugs, and Probiotics & Prebiotics. The Probiotics & Prebiotics is projected to witness significant market share during forecast period.
Based on Application, market is studied across Autoimmune Diseases, Gastrointestinal Disorders, Infectious Diseases, and Metabolic Disorders. The Gastrointestinal Disorders is projected to witness significant market share during forecast period.
Based on End-use, market is studied across Academic & Research Institutions and Hospitals & Clinics. The Hospitals & Clinics is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 37.84% in 2023, followed by Europe, Middle East & Africa.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/microbiome-therapeutics?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Microbiome Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Microbiome Therapeutics Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Microbiome Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Alveolus Bio, Assembly Biosciences, Inc, Axial Therapeutics, Inc., BioGaia AB, Enterome SA, Ferring B.V., Intralytix, Inc., Kanvas Biosciences, Locus Biosciences, Inc., MaaT Pharma, Microba Group, Microbiotica Limited, Osel, Inc., PharmaBiome AG, Pylum Biosciences, Rebiotix Inc., Second Genome Inc., Seres Therapeutics, Inc., Servatus Limited, Synlogic Inc., Theriva Biologics, Inc., Vedanta Biosciences, Inc., Viome, and Yakult Honsha Co., Ltd..
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Microbiome Therapeutics Market, by Type
7. Microbiome Therapeutics Market, by Application
8. Microbiome Therapeutics Market, by End-use
9. Americas Microbiome Therapeutics Market
10. Asia-Pacific Microbiome Therapeutics Market
11. Europe, Middle East & Africa Microbiome Therapeutics Market
12. Competitive Landscape
13. Competitive Portfolio
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Microbiome Therapeutics Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Microbiome Therapeutics Market?
3. What is the competitive strategic window for opportunities in the Microbiome Therapeutics Market?
4. What are the technology trends and regulatory frameworks in the Microbiome Therapeutics Market?
5. What is the market share of the leading vendors in the Microbiome Therapeutics Market?
6. What modes and strategic moves are considered suitable for entering the Microbiome Therapeutics Market?
Read More @ https://www.360iresearch.com/library/intelligence/microbiome-therapeutics?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Microbiome Therapeutics Market worth $510.87 million by 2030, growing at a CAGR of 21.44% - Exclusive Report by 360iResearch here
News-ID: 3404688 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Microbiome
Microbiome Sequencing Service Market Expanding Rapidly with Advances in Microbio …
Market Overview
The microbiome sequencing service market is estimated to be valued at USD 2.19 Bn in 2025 and is expected to reach USD 4.64 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.
Coherent Market Insights has released a comprehensive new report offering an in-depth analysis of the Microbiome Sequencing Service Market from 2025 to 2032. This study provides reliable global and regional projections,…
Global Microbiome Market | Global Microbiome Industry | Global Microbiome Market …
The microbiome market comprises of sales of bioactive molecules and linked products which are utilized as immunotherapeutic agents in pharmaceuticals industry. The microbiome market is principally engaged in the improvement and sales of such bioactive products which are utilized as immunotherapy for a wide variability of conditions such as infectious syndromes, endocrine & metabolic disorders, inflammatory conditions, cancer, irritable bowel syndrome, neurological syndromes, hematological disorders and cardiovascular sickness as well.
According…
Global Microbiome Sequencing Services Market to 2022| Metabiomics, Microbiome Th …
Albany, NY, 29th January : Recent research and the current scenario as well as future market potential of "Microbiome Sequencing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022" globally.
Global Microbiome Sequencing Services Market: Overview
The global microbiome sequencing services market is profiled in detail in the report with the help of detailed historical databases, which illustrate the historical growth patterns of the microbiome sequencing…
Improved microbiome sequencing capabilities are likely to boost the global micro …
According to the latest market report published by Persistence Market Research, titled ‘Microbiome Therapeutics Market Potential: Global Pipeline Analysis and Assessment 2018 – 2025’, the global microbiome therapeutics market is expected to exhibit an exponential CAGR of 62.9% during the forecast period 2018–2025.
Request for sample report: https://www.persistencemarketresearch.com/samples/7990
Persistence Market Research estimates that the global market for microbiome therapeutics is expected to be valued at US$ 10.1 Mn in 2018 and is…
Global Microbiome Sequencing Services Market to 2022| Metabiomics, Microbiome Th …
Albany, NY, 1st November : Recent research and the current scenario as well as future market potential of "Microbiome Sequencing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022" globally.
Global Microbiome Sequencing Services Market: Overview
The global microbiome sequencing services market is profiled in detail in the report with the help of detailed historical databases, which illustrate the historical growth patterns of the microbiome sequencing…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
